C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 76 filers reported holding C4 THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $6,720,000 | +16.3% | 766,231 | 0.0% | 0.20% | +7.7% |
Q2 2022 | $5,777,000 | -88.6% | 766,231 | -63.2% | 0.18% | -82.1% |
Q1 2022 | $50,526,000 | -64.5% | 2,082,723 | -52.9% | 1.01% | -7.7% |
Q4 2021 | $142,252,000 | +41.0% | 4,417,826 | +95.6% | 1.10% | -25.2% |
Q3 2021 | $100,913,000 | -41.0% | 2,258,566 | -50.0% | 1.47% | +32.1% |
Q2 2021 | $170,928,000 | +46.3% | 4,517,132 | +43.0% | 1.11% | -24.8% |
Q1 2021 | $116,835,000 | +11.7% | 3,158,566 | 0.0% | 1.48% | +31.5% |
Q4 2020 | $104,643,000 | – | 3,158,566 | – | 1.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 1,990,334 | $3,702,021 | 3.36% |
Lynx1 Capital Management LP | 1,019,230 | $1,895,768 | 1.25% |
Soleus Capital Management, L.P. | 2,692,020 | $5,007,157 | 0.46% |
TCG Crossover Management, LLC | 1,276,574 | $2,374,427 | 0.35% |
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $3,054,511 | 0.34% |
Nextech Invest Ltd. | 375,857 | $699,094 | 0.21% |
Nantahala Capital Management | 1,000,000 | $1,860,000 | 0.16% |
WASATCH ADVISORS LP | 6,247,141 | $11,619,682 | 0.07% |
ArrowMark Colorado Holdings LLC | 2,376,806 | $4,420,859 | 0.05% |
XTX Topco Ltd | 96,042 | $178,638 | 0.03% |